Characterizing antibodies for cancer research
Proteomic and Antibody Production and Characterization
This study is looking at how certain antibodies work to fight cancer, using special technology to better understand them, which could lead to better tests and treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10687911 on NIH RePORTER |
What this research studies
This research focuses on the comprehensive characterization of antibodies that are crucial for cancer research. It utilizes advanced techniques such as Mass Spectrometry to analyze proteins and their interactions, which can help in understanding how antibodies function in the immune response against cancer. Patients may benefit from the development of more effective diagnostic and therapeutic tools based on these findings. The research is conducted at the Antibody Characterization Laboratory in Frederick, MD.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with cancer who may benefit from new antibody therapies.
Not a fit: Patients with non-cancerous conditions or those not involved in antibody-related treatments may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved antibody-based therapies and diagnostics for cancer patients.
How similar studies have performed: Previous research has shown success in using Mass Spectrometry for proteomic analysis, indicating a promising approach for this study.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.